Showing 14,721 - 14,740 results of 104,189 for search '(( 50 ((nn decrease) OR (we decrease)) ) OR ( 5 ((step decrease) OR (a decrease)) ))', query time: 1.51s Refine Results
  1. 14721
  2. 14722
  3. 14723

    Table_3_EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.XLSX by Hongda Pan (6996182)

    Published 2021
    “…<p>Background and Objective: Exosome component 5 (EXOSC5) is a novel cancer-related gene that is aberrantly expressed in various malignances. …”
  4. 14724

    Table_2_EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.DOCX by Hongda Pan (6996182)

    Published 2019
    “…<p>Background and Objective: Exosome component 5 (EXOSC5) is a novel cancer-related gene that is aberrantly expressed in various malignances. …”
  5. 14725

    Data_Sheet_1_Niclosamide as a chemical probe for analyzing SARS-CoV-2 modulation of host cell lipid metabolism.zip by Timothy J. Garrett (7418819)

    Published 2023
    “…</p>Methods<p>We used niclosamide (NIC), a poorly soluble anti-helminth drug identified initially for repurposed treatment of COVID-19, which activates the cells’ autophagic and lipophagic processes as a chemical probe to determine if it can modulate the host cell’s total lipid profile that would otherwise be either amplified or reduced during SARS-CoV-2 infection.…”
  6. 14726
  7. 14727

    Table_3_EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.XLSX by Hongda Pan (6996182)

    Published 2019
    “…<p>Background and Objective: Exosome component 5 (EXOSC5) is a novel cancer-related gene that is aberrantly expressed in various malignances. …”
  8. 14728
  9. 14729

    Table_3_EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.XLSX by Hongda Pan (6996182)

    Published 2019
    “…<p>Background and Objective: Exosome component 5 (EXOSC5) is a novel cancer-related gene that is aberrantly expressed in various malignances. …”
  10. 14730
  11. 14731

    Table_2_EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.DOCX by Hongda Pan (6996182)

    Published 2019
    “…<p>Background and Objective: Exosome component 5 (EXOSC5) is a novel cancer-related gene that is aberrantly expressed in various malignances. …”
  12. 14732

    Image_2_Myricetin, the Main Flavonoid in Syzygium cumini Leaf, Is a Novel Inhibitor of Platelet Thiol Isomerases PDI and ERp5.tiff by Renato Simões Gaspar (8384040)

    Published 2020
    “…Additionally, myricetin is a novel inhibitor of ERp5 and PDI, unveiling a new therapeutic perspective for the treatment of thrombotic disorders.…”
  13. 14733
  14. 14734
  15. 14735

    Image_4_Myricetin, the Main Flavonoid in Syzygium cumini Leaf, Is a Novel Inhibitor of Platelet Thiol Isomerases PDI and ERp5.jpeg by Renato Simões Gaspar (8384040)

    Published 2020
    “…Additionally, myricetin is a novel inhibitor of ERp5 and PDI, unveiling a new therapeutic perspective for the treatment of thrombotic disorders.…”
  16. 14736
  17. 14737
  18. 14738

    Table 5_Does COVID-19 vaccination affect risk perception and adherence to preventive behaviors? A systematic review and meta-analysis.docx by Michele Sorrentino (16538214)

    Published 2025
    “…Potential biases were assessed using the MMAT tool. A meta-analysis calculated pooled effect sizes across subgroups.…”
  19. 14739

    Image_1_Myricetin, the Main Flavonoid in Syzygium cumini Leaf, Is a Novel Inhibitor of Platelet Thiol Isomerases PDI and ERp5.tif by Renato Simões Gaspar (8384040)

    Published 2020
    “…Additionally, myricetin is a novel inhibitor of ERp5 and PDI, unveiling a new therapeutic perspective for the treatment of thrombotic disorders.…”
  20. 14740

    Image_5_The harmful intestinal microbial community accumulates during DKD exacerbation and microbiome–metabolome combined validation in a mouse model.tif by Jin Shang (704634)

    Published 2022
    “…Untargeted metabolome–microbiome combined analysis of mouse models helps decipher the pathogenetic mechanism from a metabolic perspective.</p>Results<p>The diversity of the gut microbiome was significantly decreased in DKD patients when compared with that of the non-DKD population and was increased in the patients with more advanced DKD stages. …”